
NYSEARCA:IXJ
Ishares Trust S & P Global Healthcare Index (IXJ) is covered by Stockchase stock experts. Read their latest opinions, ratings and top picks below.
Healthcare has been one of the spaces that has had very good earnings growth in the S&P and probably global as well. A very stable space. Probably a little bit of a stretch in terms of valuation. He tends to like some of the biotech names. Feels healthcare will continue to run because of the need to own something more secure and put into things that have a nice dividend. Very little volatility.
Ishares Trust S & P Global Healthcare Index is a American stock, trading under the symbol IXJ (previously IXJ-N on Stockchase) on the NYSE Arca (IXJ). It is usually referred to as AMEX:IXJ or IXJ
In the last year, 1 stock analyst issued a Buy, Sell, or Hold rating on IXJ (previously IXJ-N on Stockchase). 1 analyst recommended to BUY and 0 analysts recommended to SELL the stock. The latest stock analyst rating is WEAK BUY. Read the latest stock experts' ratings for Ishares Trust S & P Global Healthcare Index.
Ishares Trust S & P Global Healthcare Index was recommended as a Top Pick by Stan Wong on 2025-11-13. Read the latest stock experts ratings for Ishares Trust S & P Global Healthcare Index.
Earnings reports or recent company news can cause the stock price to drop. Read stock experts' recommendations for Ishares Trust S & P Global Healthcare Index.
Ishares Trust S & P Global Healthcare Index is followed by 18 investors on Stockchase and is a trending stock that is worth watching.
On 2026-09-29, Ishares Trust S & P Global Healthcare Index (IXJ) stock closed at a price of $103.65.
For healthcare, you really need to look south of the border. Limited offerings in Canada, where it's either marijuana or senior living.
Consider either IXJ or XHC, depending on what currency you want to purchase in. Broad-based, with major large-cap healthcare names. Pharma, healthcare products, services, and includes UNH. Likes the space, as you get both defensive and growth characteristics.
Yes, it is fairly steady, but healthcare is always subject to things happening from government (especially in the US) such as pricing pressure. So that could cause a bit of volatility.